What smart money is saying about Austco Healthcare Limited
AHC.AX
No fund has written a full thesis on Austco Healthcare Limited in our archive, but 1 fund letter reports a position in it, most recently TAMIM Fund Australia All Cap in June 2025.
Get an email when a fund buys, sells or pitches it
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Austco Healthcare Limited on record in the archive was reported in Q2 2025, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2025 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position
- June 2025
“Austco Healthcare Limited (ASX: AHC) has provided a trading update and guidance upgrade for FY25. Highlights include: • Revenue: $80-$82 million, up 37%-41% from FY24 • EBITDA: $12.5-$13.5 million, up 54%-67% from FY24 • Cash at bank: $14.4 million, up 6% from FY24 • Unfilled contracted revenue: $55.8 million • Amentco acquisition outperformed expectations, leading to an additional $2.5 million earn-out expense • G&S Technologies acquisition completed on 30 May 2025, funded through operating cash flows AHC unfilled order book closed the year at $50m with a strong pipeline of opportunities. We anticipate FY26 Ebitda of at least $16m and an EPS of 2.8-3 cents. The stock has reached an inflection point of a market cap above $100m and an undemanding multiple - which should attract more eyeballs to the stock and potential investors to the register.”
Austco Healthcare Limited
Read the letters behind these Austco Healthcare Limited positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger